Functional Excipients for the Formulation of Solid Oral Dosage Forms
Fully Formulated Conventional and Modified Release Film Coating Systems
The Art of Color Selection
Specialty products and services for the dietary/food/nutritional supplement industry
Tablet Design, Anti-counterfeit Technologies
Information on a Variety of Applications to Enhance Food Products
Alphabetical Listing of All Products
Products by Excipient Functionality
Formulation Information for Specific Applications
Technical Information for Solid Oral Dosage Manufacturing Processes
Useful Tools for the Pharmaceutical Formulator
Technical formulation and development seminars and forums
Global Customer Support and Service Locations
Global Regulatory Support Services
Frequently Asked Question Search
Global Technical Support, Technical Service Labs and Tablet Design Centers
Useful Tools to Assist Pharmaceutical Product Development
Extensive Collection of Articles, Product Literature, Application Data and Regulatory Documents
Technical Formulation and Development Seminars and Forums
StarCap 1500® utilized in a direct fill Capsule Formulation of a high dose / High solubility active drug - Gabapentin Capsules 300mgDiscusses the formulation of a commercially viable gabapentin capsule formulation using StarCap 1500.
Starting Formulation - Formulation Used to Produce Gabapentin (300mg) Capsules
StarCap 1500® Information Sheet
AAPS 2007 Development of a Common Cyclobenzaprine Formulation for Both Encapsulation and Tabletting Using StarCap 1500®Feasiblity study of using a common formula that can be encapsulated into hard gelatin capsules for clinical trials and subsequently compressed into tablets for commercialization. Results show that the common formula has all the key properties required for the manufacture of hard gelatin capsules and film coated tablets by a direct blend/encapsulation and direct compression process.
AAPS 2010 - Application of StarCap 1500® as Filler/Binder/Disintegrant in a Roller Compaction Dry Granulation FormulationIn this study, the feasibility of using a combination of StarCap 1500®, co-processed starch excipient, and microcrystalline cellulose (MCC)in the development of a roller compaction formulation of a slightly soluble model drug was evaluated.
AAPS 2010 - Evaluation of StarCap 1500® as an Excipient in Extended Release Hydrophilic Matrix SystemsThe objective of the present study was to evaluate the use of StarCap 1500, a unique co-processed mixture of globally accepted excipients, corn starch and pregelatinized starch, as an alternative filler in hydrophilic matrices of HPMC or PEO using different model drugs.
Evaluation of StarCap 1500® in a Propranolol Hydrochloride CapsuleCompares the flow properties of StarCap 1500 to other excipients commonly used in capsule filling and evaluates the performance of StarCap 1500 in a hard gelatin capsule formulation.
